NCB-0594

N/A

Report date: 2022/10/21 17:09:09
NME

Base Information

Drug NameNCB-0594
Drug Alias NameNCB-0594
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWnt signalling pathway inhibitorsTRAF2 and NCK-interacting protein kinase inhibitors
TargetsTRAF2 and NCK-interacting protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCarna Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A